KR20140127874A - 요실금 및 야뇨증을 치료하기 위한 약학적 조성물 - Google Patents

요실금 및 야뇨증을 치료하기 위한 약학적 조성물 Download PDF

Info

Publication number
KR20140127874A
KR20140127874A KR1020147025535A KR20147025535A KR20140127874A KR 20140127874 A KR20140127874 A KR 20140127874A KR 1020147025535 A KR1020147025535 A KR 1020147025535A KR 20147025535 A KR20147025535 A KR 20147025535A KR 20140127874 A KR20140127874 A KR 20140127874A
Authority
KR
South Korea
Prior art keywords
composition
enuresis
urinary incontinence
treatment
extract
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1020147025535A
Other languages
English (en)
Korean (ko)
Inventor
주안 칼로스 롭리갓 어거스티
Original Assignee
라보라텍, 에스.엘.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 라보라텍, 에스.엘. filed Critical 라보라텍, 에스.엘.
Publication of KR20140127874A publication Critical patent/KR20140127874A/ko
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/348—Cannabaceae
    • A61K36/3486—Humulus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
KR1020147025535A 2012-02-15 2013-01-22 요실금 및 야뇨증을 치료하기 위한 약학적 조성물 Withdrawn KR20140127874A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ESP201230242 2012-02-15
ES201230242A ES2423254B1 (es) 2012-02-15 2012-02-15 Composición farmacéutica para el tratamiento de incontinencia urinaria y enuresis
PCT/ES2013/070022 WO2013121061A1 (es) 2012-02-15 2013-01-22 Composición farmacéutica para el tratamiento de incontinencia urinaria y enuresis

Publications (1)

Publication Number Publication Date
KR20140127874A true KR20140127874A (ko) 2014-11-04

Family

ID=48983578

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020147025535A Withdrawn KR20140127874A (ko) 2012-02-15 2013-01-22 요실금 및 야뇨증을 치료하기 위한 약학적 조성물

Country Status (20)

Country Link
US (1) US9272011B2 (enExample)
EP (1) EP2815755A4 (enExample)
JP (1) JP6203761B2 (enExample)
KR (1) KR20140127874A (enExample)
CN (1) CN104254338B (enExample)
AU (1) AU2013220284A1 (enExample)
BR (1) BR112014020154A8 (enExample)
CA (1) CA2864426A1 (enExample)
CL (1) CL2014002128A1 (enExample)
CO (1) CO7141408A2 (enExample)
CR (1) CR20140419A (enExample)
EA (1) EA028184B1 (enExample)
ES (1) ES2423254B1 (enExample)
IL (1) IL233978A0 (enExample)
MA (1) MA37324A1 (enExample)
MX (1) MX367671B (enExample)
PE (1) PE20142324A1 (enExample)
PH (1) PH12014501823A1 (enExample)
WO (1) WO2013121061A1 (enExample)
ZA (1) ZA201406668B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110339316B (zh) * 2019-08-09 2021-09-21 河南中医药大学 一种治疗中风后尿失禁的中药
CN116036153B (zh) * 2023-02-22 2023-09-26 深圳市儿童医院 啤酒花提取物在制备用于治疗或者预防抑郁症、抑郁症并发症、焦虑症的产品中的应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU9137091A (en) 1990-11-27 1992-06-25 Northwestern University Gaba and l-glutamic acid analogs for antiseizure treatment
AU677008B2 (en) 1992-05-20 1997-04-10 Northwestern University Gaba and L-glutamic acid analogs for antiseizure treatment
AU779262B2 (en) * 1999-04-08 2005-01-13 Warner-Lambert Company Method for the treatment of incontinence
FR2823672B1 (fr) * 2001-04-23 2004-03-12 Berkem Sa Extraits de houblon et leur utilisation dans la preparation d'un medicament ayant des proprietes oestrogenes
JP2003088335A (ja) * 2001-09-14 2003-03-25 Pharmafoods Kenkyusho:Kk 排尿機能改善用食品組成物及びそれを含有する飲食品
GB0306568D0 (en) * 2003-03-21 2003-04-30 Unilever Plc Compositions of natural products and use thereof
NZ526350A (en) * 2003-06-09 2004-10-29 A Anti-aging compositions comprising an amino acid, vitamin B complex, metal salt and an amino alcohol
ZA200601975B (en) * 2003-09-11 2007-05-30 Xenoport Inc Treating and/or preventing urinary incontinence using prodrugs of GABA analogs
JP4815558B2 (ja) * 2003-10-09 2011-11-16 パシフィック アロー リミテッド Ｘａｎｔｈｏｃｅｒａｓｓｏｒｂｉｆｏｌｉａ抽出物を含む組成物、該抽出物から単離された化合物、それらを調製する方法、およびそれらの使用
US20070116839A1 (en) * 2005-11-23 2007-05-24 The Coca-Cola Company High-Potency Sweetener Composition With C-Reactive Protein Reducing Substance and Compositions Sweetened Therewith
EP1889612A3 (en) * 2006-07-24 2008-03-19 Jan Kees Piet Bruinstroop Method for controlling micturition
US20090180999A1 (en) * 2008-01-11 2009-07-16 U.S. Nutraceuticals, Llc D/B/A Valensa International Method of preventing, controlling and ameliorating urinary tract infections using cranberry derivative and d-mannose composition

Also Published As

Publication number Publication date
IL233978A0 (en) 2014-09-30
EP2815755A1 (en) 2014-12-24
WO2013121061A1 (es) 2013-08-22
CO7141408A2 (es) 2014-12-12
CN104254338B (zh) 2019-05-31
CN104254338A (zh) 2014-12-31
ES2423254A1 (es) 2013-09-18
CL2014002128A1 (es) 2015-03-13
US20150044308A1 (en) 2015-02-12
EA201491437A1 (ru) 2015-06-30
EP2815755A4 (en) 2015-08-05
BR112014020154A2 (enExample) 2017-06-20
MA37324A1 (fr) 2016-03-31
MX367671B (es) 2019-08-30
US9272011B2 (en) 2016-03-01
EA028184B1 (ru) 2017-10-31
JP6203761B2 (ja) 2017-09-27
PE20142324A1 (es) 2015-01-16
CR20140419A (es) 2014-11-28
AU2013220284A1 (en) 2014-09-25
BR112014020154A8 (pt) 2017-07-11
ES2423254B1 (es) 2014-03-26
PH12014501823A1 (en) 2014-11-24
JP2015507002A (ja) 2015-03-05
ZA201406668B (en) 2016-05-25
MX2014009464A (es) 2014-11-12
CA2864426A1 (en) 2013-08-22

Similar Documents

Publication Publication Date Title
CN102802636A (zh) 藏花素水解产物
Sharma et al. Health benefits of lavender (Lavandula angustifolia)
AU2017101878A4 (en) Gynostemma pentaphyllum containing health care pharmaceutical composition for preventing hyperlipidemia, hypertension, hyperglycemia, and gout
JP2012140437A (ja) 肥満、肥満に関連する障害、および他の障害の治療／管理におけるプレグナン配糖体の使用
US20040185014A1 (en) Sleep inducing toothpaste made with natural herbs and a natural hormone
CN110448598A (zh) 一种医用水溶性大麻二酚cbd制剂配方
WO2013051727A1 (ja) 睡眠の質改善剤
RU2431494C1 (ru) Антипаразитарный сбор
KR20140127874A (ko) 요실금 및 야뇨증을 치료하기 위한 약학적 조성물
CN102688230B (zh) 原花青素b2的用途
KR101971574B1 (ko) 윈터체리뿌리, 산뽕나무 및 보이차 추출물을 포함하는 수면 장애 개선 또는 숙면 유지용 화장료 조성물
KR101511699B1 (ko) 광천수가 함유된 아토피 피부염 개선용 조성물
KR101720681B1 (ko) 호프 추출물을 포함하는 수면 촉진용 조성물
US8530433B2 (en) Use of icariside II in manufacture of products for preventing or treating male or female sexual dysfunction
Solihati et al. The Effect of Clitoria Ternatea's Drink on Insomnia in Post COVID-19 Patients
DE202018105573U1 (de) Pharmazeutische Zusammensetzung zur Behandlung der Harninkontinenz und Enuresis
CN112546014B (zh) 一种中药解酒护肝泡腾片及其制备方法
KR20170109875A (ko) 녹차추출물을 함유하는 건강식품조성물
CN108079049A (zh) 党参黄芪组合物用于制备治疗抑郁症的药物的用途
Khan et al. A review on phytochemical, pharmacological and therapeutic effects of Rauvolfia serpentina
TW202310829A (zh) 夜間頻尿、中途覺醒或頻尿的預防或改善劑
CN115025173A (zh) 一种含大麻二酚cbd提取物用于辅助睡眠药物应用
Sharma et al. PHARMACOLOGICAL PROPERTIES OF RAUVOLFIA SERPENTINA
KR20210039366A (ko) 시계꽃 추출물을 함유하는 간질의 개선, 예방 또는 치료용 조성물
WO2021106857A1 (ja) 尿意ストレス予防または緩和用組成物及び睡眠改善用組成物

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20140912

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid